These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7163561)
41. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis. Bahr MJ; Böker KH; Horn W; Günzler V; Manns MP Hepatogastroenterology; 1997; 44(16):1200-5. PubMed ID: 9261625 [TBL] [Abstract][Full Text] [Related]
42. [Quantitative correlation between C-reactive protein and other immunity factors in hepatic diseases]. Pérez Miranda M; Borda Celaya F; Ortíz de Landazúri E Rev Clin Esp; 1973 Jun; 130(1):19-28. PubMed ID: 4755582 [No Abstract] [Full Text] [Related]
44. [Clinical evaluation of quantitative determination of immunoglobulins and complement in ulcerative colitis]. Stachowiak C; Górny MK; Zeromski J Pol Tyg Lek; 1980 May; 35(21):773-6. PubMed ID: 7413501 [No Abstract] [Full Text] [Related]
45. [Idiopathic cryoglobulinemic syndromes. Serological and immunopathological studies in cryoglobulinemic hepatitis]. Buonanno G; De Bellis G; Gonnella F; Cantore N; Volpe E; Valente A Recenti Prog Med; 1980 Jun; 68(6):569-81. PubMed ID: 7455319 [No Abstract] [Full Text] [Related]
46. A defective autologous mixed lymphocyte reaction in patients with idiopathic portal hypertension. Tokushige K; Komatsu T; Ohzu K; Yamauchi K; Obata H J Gastroenterol Hepatol; 1992; 7(3):270-3. PubMed ID: 1535230 [TBL] [Abstract][Full Text] [Related]
47. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Tanaka M; Wanless IR Hepatology; 1998 Feb; 27(2):488-96. PubMed ID: 9462648 [TBL] [Abstract][Full Text] [Related]
48. [Assessment of portal hypertension in hepatic cirrhosis in relation to etiologic factors]. Aiello A; Calapristi I; Freni MA; Fava A; Scarpignato EM; Spadaro A; Ferraú O Minerva Gastroenterol Dietol; 1993 Mar; 39(1):1-5. PubMed ID: 8357880 [TBL] [Abstract][Full Text] [Related]
49. [Cirrhosis of the liver without portal hypertension (author's transl)]. Cortinovis A; Crippa A; Bellorini R Chir Ital; 1980 Oct; 32(5):996-1005. PubMed ID: 7249193 [TBL] [Abstract][Full Text] [Related]
50. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583 [TBL] [Abstract][Full Text] [Related]
51. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484 [TBL] [Abstract][Full Text] [Related]
52. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study. Sörös P; Böttcher J; Weissenborn K; Selberg O; Müller MJ J Gastroenterol Hepatol; 2008 Apr; 23(4):606-10. PubMed ID: 18005013 [TBL] [Abstract][Full Text] [Related]
53. Surgical treatment of a patient with idiopathic portal hypertension and hepatic encephalopathy. Ohta M; Shimada T; Matsufuji H; Yukizane T; Yamada H; Sugimachi K Hepatogastroenterology; 2001; 48(41):1461-3. PubMed ID: 11677987 [TBL] [Abstract][Full Text] [Related]
54. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. Romero-Gómez M; Ramos-Guerrero R; Grande L; de Terán LC; Corpas R; Camacho I; Bautista JD J Hepatol; 2004 Jul; 41(1):49-54. PubMed ID: 15246207 [TBL] [Abstract][Full Text] [Related]
55. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263 [TBL] [Abstract][Full Text] [Related]
56. Transjugular intrahepatic portosystemic shunt prior to cardiac surgery with cardiopulmonary bypass in patients with cirrhosis and portal hypertension. Semiz-Oysu A; Moustafa T; Cho KJ Heart Lung Circ; 2007 Dec; 16(6):465-8. PubMed ID: 17446133 [TBL] [Abstract][Full Text] [Related]
57. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients. McGovern BH; Golan Y; Lopez M; Pratt D; Lawton A; Moore G; Epstein M; Knox TA Clin Infect Dis; 2007 Feb; 44(3):431-7. PubMed ID: 17205454 [TBL] [Abstract][Full Text] [Related]
58. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications]. Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817 [TBL] [Abstract][Full Text] [Related]
59. [Hepatic encephalopathy after TIPS--retrospective study]. Stefánková J; Fejfar T; Safka V; Hůlek P; Krajina A; Fendrichová M Vnitr Lek; 2002 May; 48(5):390-5. PubMed ID: 12061205 [TBL] [Abstract][Full Text] [Related]
60. [Surgical handling of primary hepatic carcinoma with severe cirrhosis and portal hypertension]. Li T; Pi Z; Liu G Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):500-2. PubMed ID: 10072989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]